Global and Chinese burden of non-alcoholic fatty liver disease in chronic liver disease: Findings from the Global Burden of Disease Study 2021

• Published in: Chinese medical journal Vol. 138; no. 14; pp. 1741 - 1751
• Main Authors: Zhao, Xinyu, Xu, Dong, Ji, Wei, Lu, Zhengzhao, Huang, Cheng, Zhao, Jingjie, Xiao, Tingting, Wang, Dongxu, Kong, Yuanyuan, Jia, Jidong, You, Hong
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 20.07.2025; Lippincott Williams & Wilkins Ovid Technologies; Wolters Kluwer
• Subjects: Adult; Aged; China - epidemiology; Chronic Disease; Chronic illnesses; Diabetes; Disability-Adjusted Life Years; Estimates; Fatty liver; Female; Global Burden of Disease; Global health; Heart failure; Hepatitis B; Hepatitis C; Humans; Incidence; Liver cirrhosis; Liver diseases; Liver Diseases - epidemiology; Male; Middle Aged; Mortality; Non-alcoholic Fatty Liver Disease - epidemiology; Non-alcoholic Fatty Liver Disease - mortality; Original; Parameter estimation; Prevalence; Quality-Adjusted Life Years; China; United States > US; Latin America; Global Burden of Disease Study; Liver diseases; Non-alcoholic fatty liver disease; Disease burden

Abstract Background: Chronic liver disease (CLD), mainly non-alcoholic fatty liver disease (NAFLD), is a significant public health concern worldwide. This study aims to quantify the burden of NAFLD in CLD globally and within China, using data from the Global Burden of Disease (GBD) Study 2021, provi...